HighTower Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-17,768
| Closed | -$121K | – | 3542 |
|
2024
Q2 | $121K | Hold |
17,768
| – | – | ﹤0.01% | 3131 |
|
2024
Q1 | $163K | Buy |
17,768
+1,630
| +10% | +$15K | ﹤0.01% | 3015 |
|
2023
Q4 | $72K | Sell |
16,138
-4,000
| -20% | -$17.8K | ﹤0.01% | 3205 |
|
2023
Q3 | $63K | Sell |
20,138
-600
| -3% | -$1.88K | ﹤0.01% | 3152 |
|
2023
Q2 | $107K | Sell |
20,738
-330
| -2% | -$1.7K | ﹤0.01% | 3031 |
|
2023
Q1 | $112K | Hold |
21,068
| – | – | ﹤0.01% | 2885 |
|
2022
Q4 | $59K | Sell |
21,068
-700
| -3% | -$1.96K | ﹤0.01% | 2955 |
|
2022
Q3 | $90K | Hold |
21,768
| – | – | ﹤0.01% | 2753 |
|
2022
Q2 | $87K | Hold |
21,768
| – | – | ﹤0.01% | 2786 |
|
2022
Q1 | $108K | Buy |
21,768
+2,500
| +13% | +$12.4K | ﹤0.01% | 2935 |
|
2021
Q4 | $134K | Buy |
19,268
+6,500
| +51% | +$45.2K | ﹤0.01% | 2844 |
|
2021
Q3 | $128K | Buy |
12,768
+2,500
| +24% | +$25.1K | ﹤0.01% | 2798 |
|
2021
Q2 | $146K | Sell |
10,268
-1,016
| -9% | -$14.4K | ﹤0.01% | 2715 |
|
2021
Q1 | $185K | Sell |
11,284
-1,376
| -11% | -$22.6K | ﹤0.01% | 2617 |
|
2020
Q4 | $261K | Buy |
+12,660
| New | +$261K | ﹤0.01% | 1998 |
|
2020
Q3 | – | Sell |
-95,639
| Closed | -$790K | – | 2383 |
|
2020
Q2 | $790K | Buy |
+95,639
| New | +$790K | ﹤0.01% | 1218 |
|